Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade-Reference-Cited by-同舟云学术

Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade

Published:2022-12-17 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Nazerai Loulieta¹²,Willis Shona Caroline¹²,Yankilevich Patricio³,Di Leo Luca¹,Bosisio Francesca Maria⁴,Frias Alex¹,Bertolotto Corine⁵⁶,Nersting Jacob²,Thastrup Maria²,Buus Soren⁷,Thomsen Allan Randrup⁷,Nielsen Morten⁸,Rohrberg Kristoffer Staal⁹,Schmiegelow Kjeld²,De Zio Daniela¹¹⁰^ORCID

Affiliation:

1. Melanoma Research Team, Danish Cancer Society Research Center, Copenhagen, Denmark

2. Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

3. Bioinformatics Core Facility, Instituto de Investigación En Biomedicina de Buenos Aires (Ibioba), Buenos Aires, Argentina

4. Lab of Translational Cell and Tissue Research, University of Leuven, Leuven, Belgium

5. Universite Côte d’Azur, Nice, France

6. INSERM, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, Centre Méditerranéen de Médecine Moléculaire, Nice, France

7. Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

8. Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, Lyngby, Denmark

9. Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

10. Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark

Funder

Børnecancerfonden

Danmarks Grundforskningsfond

LEO Fondet

Melanoma Research Alliance young investigator

Sundhedsstyrelsen

the Danish Cancer Society

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2158610

Reference50 articles.

1. The Roles of CD8+ T Cell Subsets in Antitumor Immunity

2. Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms

3. A guide to cancer immunotherapy: from T cell basic science to clinical practice

4. A decade of immune-checkpoint inhibitors in cancer therapy

5. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characterization analysis of PANoptosis-related genes in colorectal cancer based on bioinformatic analysis;PLOS ONE;2024-08-26

2. Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies;Current Cancer Drug Targets;2024-03

3. An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome;Cancer Immunology, Immunotherapy;2024-01-27

4. Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events;Pharmaceuticals;2023-11-15